1. Home
  2. VTRS vs INVH Comparison

VTRS vs INVH Comparison

Compare VTRS & INVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$14.99

Market Cap

17.2B

Sector

Health Care

ML Signal

HOLD

Logo Invitation Homes Inc.

INVH

Invitation Homes Inc.

HOLD

Current Price

$28.56

Market Cap

16.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTRS
INVH
Founded
1961
2012
Country
United States
United States
Employees
30000
N/A
Industry
Medicinal Chemicals and Botanical Products
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
17.2B
16.2B
IPO Year
2019
2016

Fundamental Metrics

Financial Performance
Metric
VTRS
INVH
Price
$14.99
$28.56
Analyst Decision
Buy
Buy
Analyst Count
4
18
Target Price
$13.50
$32.50
AVG Volume (30 Days)
8.3M
4.7M
Earning Date
05-07-2026
04-29-2026
Dividend Yield
3.21%
4.28%
EPS Growth
N/A
29.73
EPS
N/A
0.26
Revenue
$14,299,900,000.00
$2,729,296,000.00
Revenue This Year
$4.41
$2.92
Revenue Next Year
$1.96
$2.43
P/E Ratio
N/A
$30.03
Revenue Growth
N/A
4.21
52 Week Low
$8.19
$24.25
52 Week High
$16.47
$35.46

Technical Indicators

Market Signals
Indicator
VTRS
INVH
Relative Strength Index (RSI) 64.68 69.96
Support Level $12.90 $27.47
Resistance Level $15.22 $29.12
Average True Range (ATR) 0.39 0.58
MACD 0.09 0.20
Stochastic Oscillator 88.03 74.03

Price Performance

Historical Comparison
VTRS
INVH

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About INVH Invitation Homes Inc.

Invitation Homes owns a portfolio of over 85,000 single-family rental homes. The company focuses on owning homes in the starter and move-up segments of the housing market with an average sale price around $350,000 and generally less than 1,800 square feet. The portfolio is spread across 17 target markets that feature high employment and household formation growth with over 70% of the portfolio in the Western US and Florida; 15 of the 17 markets featuring average rents lower than homeownership costs.

Share on Social Networks: